BCL2 and colorectal carcinoma: Of particular note, the efficacy of drugs targeting apoptosis-related signaling such as death receptor 5 (DR5), Bcl-2 family proteins, and caspase activity have been tested in pre-clinical and clinical trials in the treatment of CRC [40].